At Azanta, we aim at maintaining open, efficient and dynamic communication with the investor market, including in particular our shareholders, equity analysts and the media in Denmark as well as internationally. As a part of this objective, we strive to ensure everyone equal and easy access to relevant information and to a dialogue with management regarding the company’s financial and business performance as well as its strategy and goals.

Articles of Association 2017.10.10

Annual Report 2018

Azanta Annual General Meeting Minutes 2019.04.30

For further interest in Azanta’s specialty pharma products or investigational cancer products, please contact your local representative or Azanta’s head office.

Find representative